title: Pertussis control: time for something new?
abstract: Childhood acellular pertussis vaccines were licensed and implemented in the US in the 1990s following an effort to improve on the safety profile of whole-cell vaccines. However, waning of immunity from acellular vaccines may be driving the recent resurgence of pertussis, raising the need to consider new prevention strategies.
authors.affiliation: Centers for Disease Control and Prevention, Division of Bacterial Diseases, 1600 Clifton Road, Mailstop C-25, Atlanta, GA 30333, USA. tnc4@cdc.gov
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Clark
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Messonnier
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Hadler
mesh_terms: D001886:Bordetella pertussis / Q000235:genetics / Q000276:immunology; D003140:Communicable Disease Control / Q000379:methods*; D006801:Humans; D010567:Pertussis Vaccine / Q000235:genetics / Q000276:immunology; D014611:Vaccination; D014917:Whooping Cough / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*
chemical_list: D010567:Pertussis Vaccine